Model
Edge
Scinai Immunotherapeutics Ltd
SCNI
Filing Type
POS AM
Filing Date
8/26/2026
Updated
8/27/26, 9:35 AM
Copy Ref
Filing
POS AM
Earnings Release
Exhibits
POS AM
Post-Effective Amendment to Registration Statement
EX-3.1
ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD
EX-4.8
FORM OF SERIES A WARRANT
EX-4.9
FORM OF SERIES B WARRANT
EX-10.4
AMENDMENT TO EMPLOYMENT AGREEMENT, DATED JUNE 16, 2026, BETWEEN THE COMPANY AND MR. REICHMAN
EX-10.6
AMENDMENT TO EMPLOYMENT AGREEMENT, DATED OCTOBER 26, 2025, BETWEEN THE COMPANY AND ELAD MARK
EX-10.9
SECOND AMENDMENT TO SERVICES AGREEMENT, DATED JUNE 23, 2026, BETWEEN THE COMPANY, CFO DIRECT AND URI BEN-OR
EX-10.22
AMENDED AND RESTATED SERVICE AGREEMENT, DATED JUNE 16, 2026, BETWEEN THE COMPANY AND MARK GERMAIN
EX-23.1
CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS IN ISRAEL, AND A MEMBER FIRM OF BDO, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.2
CONSENT OF YARON ROTEM, CPA, CERTIFIED PUBLIC ACCOUNTANT
GRAPHIC
Graphic